• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [168 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2027 Belgian Health Care Knowledge Centre (KCE) Review of new oncology indications for the use of positron emission tomography (PET-scans) (Study 2024-12)
2027 Norwegian Medical Products Agency (NOMA) [Wearable cardioverter defibrillator (LifeVest) for people with high risk of sudden cardiac arrest: a single technology assessment]
2027 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Short frenulum in infants: what are the advantages and disadvantages of frenectomy (cutting the frenulum) compared to, for example, breastfeeding counseling for breastfeeding problems?]
2027 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Anxiety and panic disorder: do those affected benefit from the "emotional freedom technique”?]
2027 Health Information and Quality Authority (HIQA) Health Technology Assessment (HTA) of the transition to, and coordination of, adult healthcare services for individuals with severe neurological impairment
2026 Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Reinforced foster homes]
2026 Swiss Federal Office of Public Health (FOPH) Superficial/deep heat in physiotherapy for musculoskeletal conditions
2026 Swiss Federal Office of Public Health (FOPH) Injection therapies with corticosteroids for chronic tendinopathy or enthesopathy
2026 Swiss Federal Office of Public Health (FOPH) Thermoablation for benign thyroid nodules
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Revision of the information materials on colorectal cancer screening]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Adhesions in the abdominal cavity: Do other measures help to relieve symptoms instead of surgery?]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Vulvodynia (itching and pain in the vulva area): What non-drug treatment options are promising?]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Quality of sleep: Can taking melatonin as a dietary supplement, e.g. in the form of tablets, sprays or soft gums, help to improve sleep?]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [X-ray image of the lung: Can artificial intelligence support the analysis of X-ray images?]
2026 Swiss Federal Office of Public Health (FOPH) Ginkgo biloba in patients with decreasing mental performance, peripheral arterial occlusive disease, vertigo or tinnitus
2026 Swiss Federal Office of Public Health (FOPH) Valerian extracts for sleep disorders, anxiety or restlessness
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Development of a decision aid for carotid revascularization surgery for carotid stenosis]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Newborn screening for metachromatic leukodystrophy]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Acupuncture for migraine prophylaxis]
2026 Center for Outcomes Research and Economic Evaluation for Health (C2H) [Cost-effectiveness evaluation of Nirmatrelvir plus ritonavir (Paxlovid)]
2026 Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Barriers and facilitators when implementing guidelines in health and social care for the elderly]
2026 Belgian Health Care Knowledge Centre (KCE) Economic evaluation based on ‘PRECISe’, a randomised clinical trial funded by the KCE Trials programme (Study 2024-92)
2026 Belgian Health Care Knowledge Centre (KCE) Assessment of a mobile application in the rehabilitation of patients undergoing primary knee or hip arthroplasty (Study 2020-01)
2026 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Safety, clinical effectiveness and cost-effectiveness of neonatal screening for Pompe disease]
2026 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Evaluation of the safety, clinical and cost-effectiveness of neonatal screening for type 1 citrullinaemia, trifunctional protein deficiency, holocarboxyl synthetase deficiency, argininosuccinic aciduria and 3-methylcrotonyl-CoA carboxylase deficiency]
2026 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Telemedicine for the follow-up of post-stroke patients]
2026 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Artificial intelligence software to detect viable tissue in stroke patients on CT or perfusion MRI of the skull]
2026 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Neurosurgical robot for electrode implantation, brain biopsies and spinal surgery]
2026 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Efficacy and safety of model-informed precision dosing of biologic agents]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Guideline synopsis for the update of the DMP "Chronic obstructive pulmonary disease (COPD)]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Local hyperbaric oxygen therapy for diabetic foot ulcers]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Fundus photography for the diagnosis of diabetic retinopathy]
2026 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Economic evaluation of a booster dose of Tdap vaccine in adolescents]
2026 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Safety, clinical effectiveness, and cost-effectiveness of neonatal screening for beta-ketothiolase deficiency and classic galactosemia. Update]
2026 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Exercise programs for cancer patients over 65 years of age undergoing chemotherapy. Systematic review]
2026 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Effectiveness and safety of endovascular treatment using transarterial radioembolization for intermediate and advanced hepatocellular carcinoma]
2026 Health Information and Quality Authority (HIQA) Protocol for modelling the risk of alcohol-attributable mortality and hospital admission in Ireland
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Relationship between quantity of services and quality of treatment outcome in corrective surgery of Hirschsprung's disease]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Local hyperbaric oxygen therapy for diabetic foot ulcers]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [CR neuromodulation: Evidence report for the S3 guideline on chronic tinnitus]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [TMNMT: Evidence report for the S3 guideline on chronic tinnitus]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Bimodal ES: Evidence report for the S3 guideline on chronic tinnitus]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [VNS: Evidence report for the S3 guideline on chronic tinnitus]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [rTMS: Evidence report for the S3 guideline on chronic tinnitus]
2026 Health Information and Quality Authority (HIQA) Scalable Training and Knowledge Exchange on guideline development for patients, public, and healthcare professionals (The STAKEholder Project)
2026 Scottish Health Technologies Group (SHTG) Virtual wards
2026 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Extracorporeal shockwave therapy for treating chronic skin wounds: pressure ulcers, diabetic foot ulcers, and vascular wounds (venous and/or arterial)]
2026 Health Information and Quality Authority (HIQA) Protocol for a systematic review on the association between alcohol consumption and mental health outcomes
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Neuromuscular electrostimulation of the common peroneal nerve for the treatment of venous leg ulcers]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Risk-adapted PSA and MRI screening for early detection of prostate cancer]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Guideline synopsis for updating the DMP “asthma”]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Guideline synopsis for updating the DMP “breast cancer”]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Relationship between volume of services and quality of treatment outcome in corrective surgery for anorectal malformations]
2026 Health Information and Quality Authority (HIQA) A health technology assessment (HTA) of cochlear implants for adults with single-sided deafness
2026 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [New surgical robotics platform for digestive oncology surgery]
2026 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Endoscopic stapler for distal pancreatectomy]
2026 Health Information and Quality Authority (HIQA) The management of acute asthma attack in adults
2026 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Irreversible electroporation for treating colorectal cancer liver metastases]
2026 Health Information and Quality Authority (HIQA) Protocol for the health technology assessment of the introduction of population-based screening for familial hypercholesterolaemia in children
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Targeted lung denervation using catheter ablation in patients with moderate to severe chronic obstructive pulmonary disease that cannot be treated or cannot be adequately treated with medication]
2026 Health Information and Quality Authority (HIQA) Protocol for a health technology assessment of modifications to the BreastCheck programme. Workstream 1 (of 2): consideration of screening pathways that incorporate breast density
2026 Health Information and Quality Authority (HIQA) Scalable training and knowledge exchange on guideline development for patients, public, and healthcare professionals (The STAKEholder Project)
2026 Scottish Health Technologies Group (SHTG) Surface guided radiation therapy (SGRT)
2026 Scottish Health Technologies Group (SHTG) Wearable home-testing devices for diagnosing obstructive sleep apnoea syndrome (OSAHS)
2026 Scottish Health Technologies Group (SHTG) Out-of-hospital cardiac arrest (OHCA)
2026 Scottish Health Technologies Group (SHTG) Robotic assisted bronchoscopy (RAB)
2026 Scottish Health Technologies Group (SHTG) Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndrome (OSAHS)
2026 Scottish Health Technologies Group (SHTG) Computed tomography fractional flow rate (CT-FFR)
2026 Scottish Health Technologies Group (SHTG) Specialist interventions for managing chronic non-malignant pain in adults
2026 Scottish Health Technologies Group (SHTG) Surgical care practitioners
2026 Health Information and Quality Authority (HIQA) Protocol for a health technology assessment of COVID-19 vaccination in Ireland
2025 NIHR Health Technology Assessment programme Protocol for DexEnceph: a randomised controlled trial of dexamethasone therapy in adults with herpes simplex virus encephalitis
2025 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Intraoperative radiation therapy for breast cancer]
2025 Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Alternative methods to coercive measures]
2025 Swiss Federal Office of Public Health (FOPH) Magnesium supplements for muscle cramps and for the prevention of recurrent urinary tract stones
2025 Swiss Federal Office of Public Health (FOPH) Point-of-care diagnostic tests
2025 Swiss Federal Office of Public Health (FOPH) Multigene-expression tests for breast cancer
2025 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical practice guideline on deprescribing antidepressants]
2025 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical practice guideline (CPG) update palliative care]
2025 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Diagnostic accuracy of ex vivo confocal microscopy during Mohs surgery for basal cell carcinomas]
2025 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Effectiveness of care models based on the incorporation of psychologists in primary care]
2025 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Safety and clinical effectiveness of cryoanalgesia in pediatric patients after surgical intervention for pectus excavatum]
2025 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Branched endovascular prostheses for the treatment of aortic arch pathology]
2025 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Early detection of graft damage in kidney and heart recipient patients using donor-derived free DNA (dd-cfDNA)]
2025 Belgian Health Care Knowledge Centre (KCE) Evaluation of novel blood-based brain biomarkers for mild traumatic brain injuries (Study 2023-11)
2025 Belgian Health Care Knowledge Centre (KCE) Update of breast cancer screening recommendations (Study 2024-11)
2025 Belgian Health Care Knowledge Centre (KCE) Update of prostate cancer screening recommendations (Study 2024-10)
2025 Belgian Health Care Knowledge Centre (KCE) Economic evaluation of whole genome sequencing for children with developmental disorders (Study 2024-09)
2025 Norwegian Medical Products Agency (NOMA) Intravenous ketamine for treatment-resistant depression
2025 Health Information and Quality Authority (HIQA) Protocol for a health technology assessment of teledermatology to support the management of primary care referrals
2025 Norwegian Medical Products Agency (NOMA) [A leadless pacemaker, MicraTM Transcatheter Pacing System, in (sub-groups of) patients with indication for single-chamber ventricular pacing: a single technology re-assessment]
2025 Norwegian Medical Products Agency (NOMA) [Magnetic resonance guided high-intensity focused ultrasound for treatment of essential tremor: single technology assessment]
2025 Norwegian Medical Products Agency (NOMA) [Photon-counting detector computed tomography]
2025 Norwegian Medical Products Agency (NOMA) Continuous and flash glucose monitoring in patients with type 2 diabetes treated with insulin
2025 Swiss Federal Office of Public Health (FOPH) Betahistine or cinnarizine with or without dimenhydrinate for Ménière’s disease/syndrome and symptoms of vestibular vertigo and/or tinnitus
2025 The Danish Health Technology Council (DHTC) [Assessment of endovascular aortic repair (EVAR)]
2025 The Danish Health Technology Council (DHTC) [Assessment of percutaneous vertebroplasty (PVP) for compression fractures]
2025 The Danish Health Technology Council (DHTC) [Assessment of Merlin Assay for diagnosis of malignant melanoma]
2025 The Danish Health Technology Council (DHTC) [Assessment of supervised gait training]
2025 The Danish Health Technology Council (DHTC) [Assessment of SelfBack App for lower back pain]